Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy

PURPOSE OF REVIEW: To help clinicians optimize the conversion of a patient's Parkinson disease pharmacotherapy from immediate-release carbidopa/levodopa (IR CD/LD) to an extended-release formulation (ER CD/LD). RECENT FINDINGS: Eleven movement disorders specialists achieved consensus positions...

Descripción completa

Detalles Bibliográficos
Autores principales: Espay, Alberto J., Pagan, Fernando L., Walter, Benjamin L., Morgan, John C., Elmer, Lawrence W., Waters, Cheryl H., Agarwal, Pinky, Dhall, Rohit, Ondo, William G., Klos, Kevin J., Silver, Dee E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310207/
https://www.ncbi.nlm.nih.gov/pubmed/28243505
http://dx.doi.org/10.1212/CPJ.0000000000000316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310207/
https://www.ncbi.nlm.nih.gov/pubmed/28243505
http://dx.doi.org/10.1212/CPJ.0000000000000316

Ejemplares similares